Estrella Immunopharma, Inc. Share Price
ESLAEstrella Immunopharma, Inc. Stock Performance
Open $1.03 | Prev. Close $1.27 | Circuit Range N/A |
Day Range $1.03 - $1.48 | Year Range $0.73 - $3.08 | Volume 33,159 |
Average Traded $1.36 |
Estrella Immunopharma, Inc. Share Price Chart
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
Estrella Immunopharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Feb-26 | $1.03 | $1.32 | +0.00% |
05-Feb-26 | $1.03 | $1.32 | +24.53% |
04-Feb-26 | $1.12 | $1.06 | -7.83% |
03-Feb-26 | $1.12 | $1.15 | +0.00% |
02-Feb-26 | $1.13 | $1.15 | +2.68% |
30-Jan-26 | $1.11 | $1.12 | +3.70% |
29-Jan-26 | $1.10 | $1.08 | +0.93% |
FAQs on Estrella Immunopharma, Inc. Share Price
Can I buy Estrella Immunopharma, Inc. shares in India?
What is the share price of Estrella Immunopharma, Inc.?
What is the 5 year returns of Estrella Immunopharma, Inc.?
What are the high & low stock price of Estrella Immunopharma, Inc. today?
What is the 52-week high and low of Estrella Immunopharma, Inc. stock?